Tumor Recurrence After Partial Hepatectomy for Liver Metastases in Rats: Prevention by In Vivo Injection of Irradiated Cancer Cells Expressing GMCSF and IL-12

Journal of Surgical Research

Volumn 149, Issue 2, 2008, Pages 184-191

  Aussilhou, Béatrice ^a   Panis, Yves ^a   Alves, Arnaud ^a   Nicco, Carole ^b   Klatzmann, David ^c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Hospital Cochin ^*  (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

antitumoral vaccination; colorectal liver metastases; cytokines; immunotherapy; interleukin 12; liver resection

Indexed keywords

CELL THERAPY AGENT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CELL; CANCER IMMUNIZATION; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOFLUOROMETRY; GENE TRANSFER; GENETIC TRANSFECTION; HISTOPATHOLOGY; IMMUNE RESPONSE; IRRADIATED CANCER CELL; LIVER METASTASIS; MALE; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; RAT; TUMOR RECURRENCE;

ANIMALS; CARCINOMA; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FLOW CYTOMETRY; GAMMA RAYS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEPATECTOMY; IMMUNOTHERAPY, ACTIVE; INJECTIONS, INTRAVENOUS; INTERLEUKIN-12; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; NEOPLASM RECURRENCE, LOCAL; RATS;

EID: 51049111847     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.12.789     Document Type: Article

References (25)

1. Kemeny N., Huang Y., Cohen A.M., et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 341 (1999) 2039
2. Panis Y., Ribeiro J., Chretien Y., et al. Dormant liver metastases: An experimental study. Br J Surg 79 (1992) 221
3. Gutierrez A.A., Lemoine N.R., and Sikora K. Gene therapy for cancer. Lancet 339 (1992) 715
4. Panis Y. Gene therapy for liver tumors. Surg Oncol Clin North Am 5 (1996) 461
5. Kianmanesh A.R., Perrin H., Panis Y., et al. A "distant" bystander effect of suicide gene therapy: Regression of nontransduced tumors together with a distant transduced tumor. Hum Gene Ther 8 (1997) 1807
6. Alves A., Charre L., Panis Y., et al. Total vascular exclusion of the liver enhances the efficacy of retroviral-mediated associated thymidine kinase and interleukin-2 genes transfer against multiple hepatic tumors in rats. Surgery 133 (2003) 669
7. Narvaiza I., Mazzolini G., and Barajas M. Intratumoral co-injection of two adenoviruses, one encoding the chemokine IFN-γ-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy. J Immunol 164 (2000) 3112
8. Rosenberg S.A., Lotze M.T., and Yang J.C. Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients. Ann Surg 210 (1989) 474 Discussion 484
9. Siegel J.P., and Puri R.K. Interleukin-2 toxicity. J Clin Oncol 9 (1991) 694
10. Cohen J. IL-12 deaths: Explanation and a puzzle. Science 270 (1995) 908
11. Caruso M., Pham-Nguyen K., Kwong Y.L., et al. Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma. Proc Natl Acad Sci USA 93 (1996) 11302
12. Rodolfo M., Zilocchi C., and Melani C. Immunotherapy of experimental metastases by vaccination with interleukin gene-transduced adenocarcinoma cells sharing tumor-associated antigens. Comparison between IL-12 and IL-2 gene-transduced tumor cell vaccines. J Immunol 157 (1996) 5536
13. Jarnagin W.R., Delman K., Kooby D., et al. Neoadjuvant interleukin-12 immunogene therapy protects against cancer recurrence after liver resection in an animal model. Ann Surg 231 (2000) 762
14. Alves A., Vibert E., Trajcevski S., et al. Adjuvant interleukin-12 gene therapy for the management of colorectal cancer liver metastases. Cancer Gene Ther 11 (2004) 782
15. Caruso M., Panis Y., Gagandeep S., et al. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc Natl Acad Sci USA 90 (1993) 7024
16. Mazzolini G., Alfaro C., Sangro B., et al. Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas. J Clin Oncol 23 (2005) 999
17. Vermorken J.B., Claessen A.M., van Tinteren H., et al. Active specific immunotherapy for Stage II and Stage III human colon cancer: A randomized trial. Lancet 353 (1999) 345
18. Patry Y., Douillard J.Y., Meflah K., et al. Immunization against a rat colon carcinoma by sodium butyrate-treated cells but not by interleukin 2-secreting cells. Gastroenterology 109 (1995) 1555
19. Lechanteur C., Moutschen M., Princen F., et al. Antitumoral vaccination with granulocyte-macrophage colony-stimulating factor or interleukin-12-expressing DHD/K12 colon adenocarcinoma cells. Cancer Gene Ther 7 (2000) 676
20. Brunda M.J., Luistro L., and Warrier R.R. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J Exp Med 178 (1993) 1223
21. Iwasawa T., Chau G.Y., and Mori T. Potent antitumor effects of intra-arterial injection of fibroblasts genetically engineered to express IL-12 in liver metastasis model of rat: No additional benefit of using retroviral producer cell. Cancer Gene Ther 8 (2001) 17
22. Dranoff G., Jaffee E., Lazenby A., et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 90 (1993) 3539
23. Nishitani M.A., Sakai T., Ishii K., et al. A convenient cancer vaccine therapy with in vivo transfer of interleukin 12 expression plasmid using gene gun technology after priming with irradiated carcinoma cells. Cancer Gene Ther 9 (2002) 156
24. Sung M.W., Chen S.H., and Thung S.N. Intratumoral delivery of adenovirus-mediated interleukin-12 gene in mice with metastatic cancer in the liver. Hum Gene Ther 6 (2002) 491
25. Pham-Nguyen K., Yang W., Saxena R., et al. Role of NK and T cells in IL-12-induced anti-tumor response against hepatic colon carcinoma. Int J Cancer 81 (1999) 813